PAULING.AI featured a conversation between Ceo Javier Tordable and Hugo Verli on how software development is changing.

Pauling.AI is an autonomous drug discovery platform that compresses early-stage research from months to days. Our AI agents orchestrate dozens of computational pipelines molecular dynamics, docking, structure prediction, and ADMET profiling, so medicinal chemists can focus on biology, not software. Built for pharma and biotech teams that need to move faster without sacrificing scientific rigor.